Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]
Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price objective lifted by HC Wainwright from $17.00 to $22.00 in a research report report published on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Olema Pharmaceuticals’ Q3 2023 earnings at ($0.54) EPS, Q4 2023 earnings […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) had its price target upped by Capital One Financial from $16.00 to $20.00 in a report released on Friday, The Fly reports. Capital One Financial‘s price target would indicate a potential upside of 190.28% from the stock’s current price. Several other equities research analysts also recently issued reports on […]